Chuiyang Zheng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study.
Journal: Scientific reports
Published: December 17, 2024
Leonurine Inhibits Hepatic Lipid Synthesis to Ameliorate NAFLD via the ADRA1a/AMPK/SCD1 Axis.
Journal: International journal of molecular sciences
Published: September 02, 2024
Atractylodes lancea Rhizome Polysaccharide Alleviates MCD Diet-Induced NASH by Inhibiting the p53/mTOR Pathway.
Journal: International journal of molecular sciences
Published: August 24, 2024
Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis.
Journal: Antioxidants (Basel, Switzerland)
Published: July 27, 2024
Exploring the relationship between air pollution, non-alcoholic fatty liver disease, and liver function indicators: a two-sample Mendelian randomization analysis study.
Journal: Frontiers in endocrinology
Published: March 05, 2024
Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 04, 2023
The AMPK-mTOR Pathway Is Inhibited by Chaihu Shugan Powder, Which Relieves Nonalcoholic Steatohepatitis by Suppressing Autophagic Ferroptosis.
Journal: Mediators of inflammation
Published: November 28, 2023
Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Journal: Journal of ethnopharmacology
Published: June 01, 2023
Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c.
Journal: Oxidative medicine and cellular longevity
Published: March 15, 2020
A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
Journal: Journal of cellular and molecular medicine
Published: November 11, 2019
Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
Journal: Molecules (Basel, Switzerland)
Published: September 30, 2019
Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 10, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026